Zobrazeno 1 - 10
of 1 423
pro vyhledávání: '"humoral rejection"'
Autor:
S. Auner, C. Hillebrand, P. M. Boehm, J. Boecker, D. Koren, S. Schwarz, Z. Kovacs, G. Murakoezy, G. Fischer, C. Aigner, K. Hoetzenecker, P. Jaksch, A. Benazzo
Publikováno v:
Transplant International, Vol 37 (2024)
Lung transplantation (LuTx) is an established treatment for patients with end-stage lung diseases, however, outcomes are limited by acute and chronic rejection. One aspect that has received increasing attention is the role of the host’s humoral all
Externí odkaz:
https://doaj.org/article/3ab0969e59e845ec86340a2155895724
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 2 (2024)
Aim. To evaluate the early and long-term outcomes of heart transplantation (HT) at the Research Institute of the S. V. Ochapovsky Regional Clinical Hospital № 1.Material and methods. On the basis of the Research Institute of the S. V. Ochapovsky Re
Externí odkaz:
https://doaj.org/article/5f6073feff0943dabc061b4f5a6fc8b8
Farnesyltransferase-inhibitors exert in vitro immunosuppressive capacity by inhibiting human B-cells
Autor:
Shilei Xu, Sebastian Dolff, Nils Mülling, Hagen S. Bachmann, Yang Dai, Monika Lindemann, Ming Sun, Oliver Witzke, Andreas Kribben, Benjamin Wilde
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
ObjectivesFarnesyltransferase inhibitors (FTI), which inhibit the prenylation of Ras GTPases, were developed as anti-cancer drugs. As additional target proteins for prenylation were identified in the past, it is likely that FTI have potential value f
Externí odkaz:
https://doaj.org/article/4f21b1f33ef84b54905aebb329722c2d
Autor:
Betty Chamoun, Pablo Sánchez-Sancho, Irina B. Torres, Alejandra Gabaldon, Manel Perelló, Joana Sellarés, Francesc Moreso, Daniel Serón
Publikováno v:
Nefrología, Vol 42, Iss 5, Pp 578-584 (2022)
Resumen: Introducción: No existe consenso sobre el tratamiento más adecuado para el rechazo humoral crónico activo (RHCa). Estudios recientes sugieren que el tratamiento con tocilizumab (TCZ) puede estabilizar la función del injerto, disminuir la
Externí odkaz:
https://doaj.org/article/a7fd333cacb94a17b985477a39cff905
Autor:
V. S. Kvan, N. N. Koloskova, Yu. A. Kachanova, N. N. Sayfullina, A. Yu. Goncharova, L. B. Krugly, A. O. Shevchenko
Publikováno v:
Вестник трансплантологии и искусственных органов, Vol 23, Iss 4, Pp 47-61 (2022)
The role of antibody-mediated rejection in predicting survival among heart recipients has been studied in clinical transplantology for over 20 years. This condition is a significant risk factor for heart failure and graft vasculopathy. Antibody-media
Externí odkaz:
https://doaj.org/article/ba9ded1c3ed240e8b3f8988736777f27
Autor:
Brinda Kakkar, Raj Nath Makroo, Soma Agrawal, Mohit Chowdhry, Sweta Nayak, Sanjiv Jasuja, Gaurav Sagar, Sandeep Guleria
Publikováno v:
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 62-67 (2021)
Background and Aim: Renal transplantation (RT) is the most successful and ideal renal replacement therapy for end-stage renal disease patients. Renal allograft rejection has always been one of the major barriers in successful RT. Our aim was to repor
Externí odkaz:
https://doaj.org/article/0cf171db1d4641e29fd864c028608f05
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 44-51 (2019)
Aim. To create a mathematical model for predicting an assessment of the risk of antibody-mediated rejection (AMR) and analyze the survival of recipients with antibodies to leukocyte donor antigens.Material and methods. A single-center study was condu
Externí odkaz:
https://doaj.org/article/cf1cd8cde84c45d393a9e593b2852209
Criteria for diagnosis of humoral rejection using the method of 2D-speckle-tracking echocardiography
Publikováno v:
Вестник трансплантологии и искусственных органов, Vol 21, Iss 1, Pp 46-56 (2019)
Aim: to identify predictors of humoral rejection at different stages using non-invasive methods of 2D-speckletracking echocardiography, to determine the correlation with immunological changes.Materials and methods. The study was conducted on the basi
Externí odkaz:
https://doaj.org/article/17c083a0274d47208551883cbe5d4d74
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
BackgroundThe impact of de novo anti-HLA donor-specific alloantibodies (DSA) which develop after long-term liver transplantation (LT) remains controversial and unclear. The aim of this study was to investigate the role of de novo DSAs on the outcome
Externí odkaz:
https://doaj.org/article/573abdfc49d24a649618c83c9cd7990e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.